Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
684
datasets available to search
ShareScore release 0.9.0
Dataset results
684 results for “Head and Neck Squamous Cell Carcinoma”
Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)
ClinicalTrials.gov study NCT00627835. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Exercise Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
ClinicalTrials.gov study NCT06839014. IPD Sharing: NO. Countries: 0. Publications: 0.
A Multicenter Phase II Trial of Post-operative Concurrent Chemoradiotherapy Using Weekly Cisplatin With Tislelizumab for Patients With High-risk Head and Neck Squamous Cell Carcinoma：The POTENTIAL Stu
ClinicalTrials.gov study NCT04814069. IPD Sharing: Not stated. Countries: 0. Publications: 0.
AK112 Plus AP Regimen for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06537011. IPD Sharing: NO. Countries: 0. Publications: 0.
Envafolimab Combined With Chemotherapy in Neoadjuvant and Conversion Therapy for Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06218004. IPD Sharing: NO. Countries: 0. Publications: 0.
SCT200 Injection in Patients With Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03744208. IPD Sharing: NO. Countries: 0. Publications: 0.
MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00427102. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT05965154. IPD Sharing: NO. Countries: 0. Publications: 0.
QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
ClinicalTrials.gov study NCT03169764. IPD Sharing: NO. Countries: 0. Publications: 0.
Trilaciclib in Preventing Hematopoietic Suppression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06714266. IPD Sharing: NO. Countries: 0. Publications: 0.
Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT00596219. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06755567. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Afatinib and Nivolumab as Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT03652233. IPD Sharing: Not stated. Countries: 0. Publications: 0.
The dual pathway inhibitor rigosertib is effective in direct-patient tumor xenografts of head and neck squamous cell carcinomas
GEO Series GSE47864. Homo sapiens. 16 samples. Type: Expression profiling by array.
N4-acetylcytidine-dependent GLMP mRNA stabilization by NAT10 promotes head and neck squamous cell carcinoma metastasis and remodels tumor microenvironment through MAPK/ERK signaling pathway
GEO Series GSE239900. Homo sapiens. 4 samples. Type: Other.
The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD complex
GEO Series GSE107591. Homo sapiens. 47 samples. Type: Expression profiling by array.
Effect of PRMT1 deletion on head and neck squamous cell carcinoma cells LIU-LSC-1
GEO Series GSE282295. Homo. 4 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
In vivo CRISPR screens reveal NOTCH regulators suppressing Head and Neck Squamous Cell Carcinoma in mice [RNA-seq]
GEO Series GSE140495. Mus musculus. 21 samples. Type: Expression profiling by high throughput sequencing.
Gene expression signatures modulated by epidermal growth factor receptor activation and their relationship to cetuximab resistance in head and neck squamous cell carcinoma
GEO Series GSE32975. Homo sapiens. 58 samples. Type: Expression profiling by array.
Gene Expression Profiles of Head and Neck Squamous Cell Carcinoma (HNSCC) primary tumors
GEO Series GSE686. Homo sapiens. 78 samples. Type: Expression profiling by array.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.